Contacto

m&a biotecnología

m&a biotecnología

Te acompañamos en cada paso
Array ( [0] => WP_Term Object ( [term_id] => 743 [name] => corporate finance biotecnología [slug] => corporate-finance-biotecnologia [term_group] => 0 [term_taxonomy_id] => 743 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [1] => WP_Term Object ( [term_id] => 617 [name] => inversores en biotecnologia [slug] => inversores-en-biotecnologia [term_group] => 0 [term_taxonomy_id] => 617 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [2] => WP_Term Object ( [term_id] => 744 [name] => invertir en biotecnología [slug] => invertir-en-biotecnologia [term_group] => 0 [term_taxonomy_id] => 744 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 1 [filter] => raw ) [3] => WP_Term Object ( [term_id] => 654 [name] => m&a biotecnología [slug] => ma-biotecnologia [term_group] => 0 [term_taxonomy_id] => 654 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) [4] => WP_Term Object ( [term_id] => 745 [name] => m&a salud [slug] => ma-salud [term_group] => 0 [term_taxonomy_id] => 745 [taxonomy] => post_tag [description] => [parent] => 0 [count] => 2 [filter] => raw ) )
Salud y Biotecnología
Operacion en Biotecnología: corporate finance, M&A, búsqueda de inversores, financiación, capital riesgo en biotecnol [...]
seguir leyendo >>
Invent Pharma y Palex: M&A sector sanitario Junio 2016
Las firmas de capital riesgo están impulsando el sector sanitario en España. Este mes hemos conocido que Corpfin ha co [...]
seguir leyendo >>
closechevron-downcrossmenuchevron-down